Posts tagged “GSK”

Updated October 3

GSK to pay $20M to resolve SEC charges in China bribery case+ SEC case summary

GSK in Zebulon   GlaxoSmithKline has agreed to pay $20 million to resolve U.S. regulators' allegations that the pharmaceutical giant's China operations bribed officials to boost drug sales. Plus: Read the SEC summary of the case.

Updated September 20

Premium Lock GSK names Emma Walmsley to replace Andrew Witty as CEO

GlaxoSmithKline picks Emma Walmsley, a female executive of its management team, to replace CEO Andrew Witty when he retires early next year. Plus: Read her bio, watch video about the news.

September 12

Premium Lock GSK sells anesthetic meds to Aspen in $372M deal

GSK's HQ in London             GlaxoSmithKline is selling its anesthetic medicine portfolio to Aspen Pharmacare in a deal worth as much as $372 million. GSK had already sold the drugs involved in U.S. and Canadian markets.

Updated August 19

Premium Lock GSK is No. 1 on Fortune 'Change the World' list; Novozymes 9th, IBM 47th

Fortune GlaxoSmithKline takes home the honor as the top business on Fortune's annual "Change the World" list. Two other tech/biotech companies with a big North Carolina presence also are recognized: Novozymes and IBM.

August 19

Premium Lock Mayne Pharma's $50M GSK deal; UNC-CH opioid drug project; SAS targets heat, disease; RTI's $2M biofuels deal

Triangle headlines In today's wrapup of tech and life science headlines from around the Triangle region: Mayne Pharma spends $50 million to acquire some GSK dermatology assets; UNC-CH researchers help develop an opioid drug candidate from scratch; SAS works with an Arizona county to fight heat and disease; and RTI International lands a $2M-plus biofuels contract.

Updated August 2

Premium Lock GSK, Google subsidiary form $714M bioelectronics venture (+ video)

‚ÄčOne of Google's sister companies will team up with pharmaceuticals firm GlaxoSmithKline to form a joint venture that aims to develop tiny implants that can tap nerves and change their electronic signals as a way of treating chronic illnesses.

June 29

Premium Lock IBM, GSK at Biden cancer summit; Mars booster fires (video); Zuck's wall; hepatitis C pill

In today's Bulldog wrapup of life science and technology news: IBM's Watson to tackle cancer and GSK to speed up drug development; NASA fires a Mars booster (see video, photos); Mark Zuckerberg's new wall angers neighbors in Hawaii; and the FDA approves a pill to treat hepatitis C.

June 23

Premium Lock Tech Links: IBM Watson medical imaging; Google, AT&T vs. FCC; Lenovo smartphone supply chain; Tencent gaming buy; good GSK drug news

High tech In today's Tech Links roundup of news impacting the Triangle: IBM forms a new Watson alliance for assessment of medical imaging - 2 reports; the FCC may budge on its cable box proposal after hearing opposition from AT&T and Google; Lenovo vows to revamp its supply chain to right smartphone business; Tencent, which owns a big part of Cary-based Epic Games, buys "Clash of Clans" creator; and GSK gets good news on a COPD combination therapy.

June 14

Premium Lock Longtime GSK exec, vaccine leader Moncef Slaoui to retire

Dr. Moncef Slaoui Dr. Moncef Slaoui, a longtime GlaxoSmithKline executive who currently heads vaccine development and who led research and development for the drug giant earlier in his career, is retiring.

Updated June 9

Premium Lock Tech links: Cisco shuffle; Chuck Robbins video; GSK arthritis drug; IBM exec on women in IT

High tech In today's wrapup of headlines on news impacting the Triangle tech community: Cisco's exec shuffle continues to generate headlines; Cisco CEO Chuck Robbins' video interview at Recode; GSK gets good news on an arthritis drug; and IBM's top IoT exec and Harriet Green on women in IT.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith